235 related articles for article (PubMed ID: 24555679)
1. Percutaneous absorption, disposition, and exposure assessment of homosalate, a UV filtering agent, in rats.
Kim TH; Shin BS; Kim KB; Shin SW; Seok SH; Kim MK; Kim EJ; Kim D; Kim MG; Park ES; Kim JY; Yoo SD
J Toxicol Environ Health A; 2014; 77(4):202-13. PubMed ID: 24555679
[TBL] [Abstract][Full Text] [Related]
2. Measurement, analysis and prediction of topical UV filter bioavailability.
Roussel L; Gilbert E; Salmon D; Serre C; Gabard B; Haftek M; Maibach HI; Pirot F
Int J Pharm; 2015 Jan; 478(2):804-10. PubMed ID: 25526673
[TBL] [Abstract][Full Text] [Related]
3. Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats.
Fediuk DJ; Wang T; Chen Y; Parkinson FE; Namaka MP; Simons KJ; Burczynski FJ; Gu X
Biopharm Drug Dispos; 2011 Oct; 32(7):369-79. PubMed ID: 21812003
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous characterization of the insect repellent DEET and the sunscreen oxybenzone from topical skin application.
Kasichayanula S; House JD; Wang T; Gu X
Toxicol Appl Pharmacol; 2007 Sep; 223(2):187-94. PubMed ID: 17602720
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of homosalate in humans after dermal application: applicability of oral-route data for exposure assessment by human biomonitoring.
Ebert KE; Griem P; Weiss T; Brüning T; Hayen H; Koch HM; Bury D
Arch Toxicol; 2024 May; 98(5):1383-1398. PubMed ID: 38485782
[TBL] [Abstract][Full Text] [Related]
6. Tissue deposition of the insect repellent DEET and the sunscreen oxybenzone from repeated topical skin applications in rats.
Fediuk DJ; Wang T; Raizman JE; Parkinson FE; Gu X
Int J Toxicol; 2010 Dec; 29(6):594-603. PubMed ID: 20959613
[TBL] [Abstract][Full Text] [Related]
7. Metabolic disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and skin administration in rats.
Fediuk DJ; Wang T; Chen Y; Parkinson FE; Namaka MP; Simons KJ; Burczynski FJ; Gu X
Int J Toxicol; 2012; 31(5):467-76. PubMed ID: 23064701
[TBL] [Abstract][Full Text] [Related]
8. Experimental methods for determining permethrin dermal absorption.
Reifenrath WG; Ross JH; Driver JH
J Toxicol Environ Health A; 2011; 74(5):325-35. PubMed ID: 21240732
[TBL] [Abstract][Full Text] [Related]
9. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
Yoshida D; Todo H; Hasegawa T; Sugibayashi K
Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Testing of Sunscreens for Dermal Absorption: A Platform for Product Selection for Maximal Usage Clinical Trials.
Yang Y; Ako-Adounvo AM; Wang J; Zhang J; Willett D; Yilmaz H; Korang-Yeboah M; Hsu HJ; Wang J; Coelho SG; Adah SA; Michele TM; Faustino PJ; Cruz CN; Lee S; Ashraf M
J Invest Dermatol; 2020 Dec; 140(12):2487-2495. PubMed ID: 32353451
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E
Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439
[TBL] [Abstract][Full Text] [Related]
12. Sunscreen penetration of human skin and related keratinocyte toxicity after topical application.
Hayden CG; Cross SE; Anderson C; Saunders NA; Roberts MS
Skin Pharmacol Physiol; 2005; 18(4):170-4. PubMed ID: 15908756
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous absorption with emphasis on sunscreens.
Gonzalez H
Photochem Photobiol Sci; 2010 Apr; 9(4):482-8. PubMed ID: 20354641
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations.
Gu X; Wang T; Collins DM; Kasichayanula S; Burczynski FJ
Br J Dermatol; 2005 Jun; 152(6):1263-7. PubMed ID: 15948991
[TBL] [Abstract][Full Text] [Related]
16. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
Matta MK; Florian J; Zusterzeel R; Pilli NR; Patel V; Volpe DA; Yang Y; Oh L; Bashaw E; Zineh I; Sanabria C; Kemp S; Godfrey A; Adah S; Coelho S; Wang J; Furlong LA; Ganley C; Michele T; Strauss DG
JAMA; 2020 Jan; 323(3):256-267. PubMed ID: 31961417
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application.
Schauer UM; Völkel W; Heusener A; Colnot T; Broschard TH; von Landenberg F; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):339-46. PubMed ID: 16814339
[TBL] [Abstract][Full Text] [Related]
19. Distribution of the UV filter 3-benzylidene camphor in rat following topical application.
Søeborg T; Ganderup NC; Kristensen JH; Bjerregaard P; Pedersen KL; Bollen P; Hansen SH; Halling-Sørensen B
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):117-21. PubMed ID: 16517225
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
